- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Hong Kong Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
7
7 companies
Consun Pharmaceutical Group
Market Cap: HK$11.6b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.79
7D
-0.6%
1Y
4.5%
CanSino Biologics
Market Cap: HK$10.9b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$25.44
7D
10.6%
1Y
-47.8%
InnoCare Pharma
Market Cap: HK$31.3b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.98
7D
8.6%
1Y
-18.6%
China Medical System Holdings
Market Cap: HK$28.6b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$11.84
7D
-1.3%
1Y
-9.3%
Beijing Luzhu Biotechnology
Market Cap: HK$2.6b
A biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China.
2480
HK$13.10
7D
-3.7%
1Y
-46.4%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.3b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.32
7D
2.7%
1Y
5.5%
Pak Fah Yeow International
Market Cap: HK$738.6m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.37
7D
1.5%
1Y
-2.5%